New Opportunities to Redefine the Advanced Parkinson’s Disease Treatment Paradigm - European Medical Journal

New Opportunities to Redefine the Advanced Parkinson’s Disease Treatment Paradigm

1 Mins
Neurology

The publication of this interactive video was funded by AbbVie. The views and opinions expressed are exclusively those of the speakers.

Parkinson’s Disease Doesn’t Sleep

This insightful interactive webinar delves into the motor and non-motor symptoms experienced by patients with Parkinson’s disease (PD) day and night. With quizzes and polls, this interactive video highlights various approaches to managing patient burden, and explores the ways in which current PD therapies may not adequately control nighttime symptoms. Experts in the field discuss how continuous dopaminergic stimulation (CDS) may provide better outcomes for these patients.

 

What’s It Really Like? Real-world Insights From 24-hour Infusion Therapy

In this interactive webinar, experts in the field analyse the use of 24-hour infusion therapy in patients with Parkinson’s disease, presenting real-world examples of the impacts and benefits of this treatment. Discussion covers the importance of patient communication and setting expectations around treatment and symptom management, and addresses the factors for clinicians to consider when choosing an infusion site.

 

Chairperson

Ray Chaudhuri1


1. Physician, Maurice Wohl Clinical Neuroscience Institute, King’s College Hospital, King’s College London, UK

Speakers

Camille Carroll2


Florin Gandor3


Eric Freire4


2. Professor of Clinical Neuroscience, Translational and Clinical Research Institute, Newcastle University, UK
3. Head of the Clinical Trials Unit, Movement Disorders Hospital, Beelitz-Heilstätten, Germany
4. Neurologist, University General Hospital of Elche, Alicante, Spain

PDUO-AA-00003-MC

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.